Raymond James Financial’s Inogen INGN Stock Holding History

Raymond James Financial’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,744	Closed	-$12.3K	–	5811
2025 Q2	$12.3K	Buy	+1,744	New	+$11.7K	﹤0.01%	5836

Other funds holding INGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Raymond James Financial's INGN Position: Q3 2025 in Review

Raymond James Financial sold out of Inogen (INGN) in Q3 2025, closing a stake of 1,744 shares — an estimated $12.3K sold.

Raymond James Financial first reported a position in INGN in Q2 2025 and held it in 1 quarter. The position peaked at $12.3K in Q2 2025. 131 funds tracked by Wall St. Rank hold INGN as of Q3 2025.

Raymond James Financial reported no remaining Inogen position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 1,744 Inogen shares in Q3 2025, an estimated $12.3K.
Raymond James Financial first reported a position in Inogen in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Inogen position peaked at $12.3K in Q2 2025.
131 funds tracked by Wall St. Rank held Inogen as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.